Alexandria Real Estate Equities (NYSE:ARE) Releases Quarterly Earnings Results

Alexandria Real Estate Equities (NYSE:ARE) issued its quarterly earnings data on Monday. The real estate investment trust reported $2.39 earnings per share for the quarter, beating the consensus estimate of $0.91 by $1.48, Zacks reports. Alexandria Real Estate Equities had a net margin of 9.62% and a return on equity of 1.31%. Alexandria Real Estate Equities updated its FY 2025 guidance to 9.230-9.430 EPS.

Alexandria Real Estate Equities Trading Up 0.4 %

Shares of ARE stock traded up $0.40 during mid-day trading on Monday, reaching $102.03. 2,658,935 shares of the stock traded hands, compared to its average volume of 1,339,028. The company has a market cap of $17.83 billion, a price-to-earnings ratio of 62.21, a price-to-earnings-growth ratio of 3.85 and a beta of 1.16. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.56. The stock’s fifty day simple moving average is $102.13 and its two-hundred day simple moving average is $112.23. Alexandria Real Estate Equities has a 1-year low of $94.35 and a 1-year high of $130.14.

Alexandria Real Estate Equities Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were paid a $1.32 dividend. This represents a $5.28 dividend on an annualized basis and a dividend yield of 5.18%. This is a boost from Alexandria Real Estate Equities’s previous quarterly dividend of $1.30. The ex-dividend date was Tuesday, December 31st. Alexandria Real Estate Equities’s dividend payout ratio is presently 321.95%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on ARE shares. JMP Securities decreased their target price on Alexandria Real Estate Equities from $140.00 to $130.00 and set a “market outperform” rating on the stock in a research report on Friday, November 15th. JPMorgan Chase & Co. downgraded Alexandria Real Estate Equities from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $133.00 to $121.00 in a report on Wednesday, November 27th. Wedbush reissued an “outperform” rating and issued a $110.00 price objective (down previously from $120.00) on shares of Alexandria Real Estate Equities in a report on Friday, December 6th. Evercore ISI lowered their target price on shares of Alexandria Real Estate Equities from $129.00 to $124.00 and set an “in-line” rating on the stock in a report on Wednesday, October 23rd. Finally, Robert W. Baird lowered their price objective on Alexandria Real Estate Equities from $137.00 to $130.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Nine equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Alexandria Real Estate Equities currently has a consensus rating of “Hold” and a consensus target price of $121.90.

Alexandria Real Estate Equities declared that its Board of Directors has initiated a share repurchase program on Monday, December 9th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the real estate investment trust to reacquire up to 2.7% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.

About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle.